Determinants of Viral Resuppression or Persistent Virologic Failure After Initial Failure With Second-Line Antiretroviral Treatment Among Asian Children and Adolescents With HIV
Year: 2019
Type: article
Study design: Observational Study
Abstract: Of 56 children with perinatally acquired human immunodeficiency virus (HIV) who had been prescribed second-line protease inhibitor-based antiretroviral therapy and had ≥1 previous episode of viral failure (HIV RNA, ≥1000 copies/mL), 46% had ≥1, 34% had ≥2, and 23% had ≥3 consecutive episodes of viral failure during the 2 years of follow-up. Two of these children experienced a major protease inhibitor mutation.
DOI: 10.1093/jpids/piz034
Institutions: HIV Netherlands Australia Thailand Research Collaboration, Chulalongkorn University, San Francisco General Hospital, University of California, San Francisco, Children's Hospital 2, Vietnam National Children's Hospital, Children's Hospital 1, Khon Kaen University, American Foundation for AIDS Research
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: G3726674119, G3936936596, G762740169, G97119092
OpenAlex ID: W2990954381
